Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy

Ann Hematol. 2016 Mar;95(4):665-6. doi: 10.1007/s00277-016-2600-7. Epub 2016 Jan 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Glioblastoma / complications*
  • Glioblastoma / diagnosis
  • Glioblastoma / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Platelet Count / trends
  • Purpura, Thrombocytopenic, Idiopathic / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / etiology*
  • Receptors, Fc / therapeutic use*
  • Recombinant Fusion Proteins / therapeutic use*
  • Thrombopoietin / therapeutic use*
  • Treatment Outcome

Substances

  • Receptors, Fc
  • Recombinant Fusion Proteins
  • Thrombopoietin
  • romiplostim